Tech Company Financing Transactions

Alpha-9 Oncology Funding Round

Ascenta Capital, Lightspeed Venture Partners and Abrdn participated in a $175 million Series C funding round for Alpha-9 Oncology. The round was announced on 10/23/2024.

Transaction Overview

Company Name
Alpha-9 Oncology
Announced On
10/23/2024
Transaction Type
Venture Equity
Amount
$175,000,000
Round
Series C
Investors

Ascenta Capital (Lead Investor) (Evan Rachlin)

Lightspeed Venture Partners (Lead Investor) (Shelley Chu)

Abrdn

Andreessen Horowitz

BVF Partners

Delos Capital

Digitalis Ventures

Frazier Life Sciences

General Catalyst

Janus Henderson Investors

Longitude Capital Management

Lumira Ventures

Nextech Invest

RA Capital Management

Samsara BioCapital

Proceeds Purpose
The company intends to use the funds to progress its pipeline. The Series C will fund human studies for the clinical stage assets and advancement of discovery stage assets to clinic-ready development candidates.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
27 E 7th Ave 300
Vancouver, BC, V5T 1M4
Canada
Phone
(778) 715-3303
Website
www.a9oncology.com
Email Address
[email protected]
Overview
Our bespoke, iterative approach to radiotherapeutic design is fueled by a toolbox of technologies for peptide-based radiopharmaceuticals. We are developing a robust pipeline of radiopharmaceuticals to address targets spanning solid and hematologic malignancies.
Profile
Alpha-9 Oncology LinkedIn Company Profile
Social Media
Alpha-9 Oncology Company Twitter Account
Company News
Alpha-9 Oncology News
Facebook
Alpha-9 Oncology on Facebook
YouTube
Alpha-9 Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Hirsch
  David Hirsch LinkedIn Profile  David Hirsch Twitter Account  David Hirsch News  David Hirsch on Facebook
Chief Financial Officer
Matthias Jaffe
  Matthias Jaffe LinkedIn Profile  Matthias Jaffe Twitter Account  Matthias Jaffe News  Matthias Jaffe on Facebook
Chief Marketing Officer
Ovid Trifan
  Ovid Trifan LinkedIn Profile  Ovid Trifan Twitter Account  Ovid Trifan News  Ovid Trifan on Facebook
Chief Operating Officer
Alison Fleming
  Alison Fleming LinkedIn Profile  Alison Fleming Twitter Account  Alison Fleming News  Alison Fleming on Facebook
Vice President
Jutta Wanner
  Jutta Wanner LinkedIn Profile  Jutta Wanner Twitter Account  Jutta Wanner News  Jutta Wanner on Facebook
VP - Bus. Development
Stephen Mitchener
  Stephen Mitchener LinkedIn Profile  Stephen Mitchener Twitter Account  Stephen Mitchener News  Stephen Mitchener on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/23/2024: Adden Energy venture capital transaction
Next: 10/23/2024: Daiki venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on tech company VC transactions. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.